Results 91 to 100 of about 2,763,581 (350)

FEATURES OF IMMUNE RESPONSE AND BASOPHIL ACTIVATION IN CHILDREN WITH CHRONIC URTICARIA

open access: yesМедицинская иммунология, 2015
Some features of peripheral bood basophil activation were studied in children with different types of chronic urticaria, in order to specify the sustaining mechanisms of chronic urticaria.
N. A. Sinelnikova   +2 more
doaj   +1 more source

Interleukin 1-β, Interleukin-1 Receptor Antagonist, and Interleukin 18 in Children with Acute Spontaneous Urticaria [PDF]

open access: yes, 2013
Very little is known about the role of interleukin-1β (IL-1β) and interleukin-18 (IL-18) in urticaria. Material and Methods. Serum levels of IL-1β, IL-1 receptor antagonist (IL-1RA), and IL-18 were measured in 56 children with urticaria and in 41 healthy
A. Kasperska-Zając   +4 more
core   +1 more source

Atopic Comorbidities Associated With Chronic Spontaneous Urticaria: A Case‐Control Analysis of the All of Us Research Program

open access: yesJEADV Clinical Practice, EarlyView.
ABSTRACT Background Chronic spontaneous urticaria (CSU) is a mast cell‐driven condition defined by recurrent wheals and/or angioedema lasting over 6 weeks without an identifiable trigger. Though CSU is known to co‐occur with atopic diseases and share Th2‐dominant immunologic pathways, prior studies have not adequately addressed these relationships in ...
Julian A. Cortes   +4 more
wiley   +1 more source

Correlation

open access: yesJournal of Dermatology and Dermatologic Surgery, 2015
Background: Chronic urticaria (CU) is a multifactorial disease, however, in a majority of patients, it is not possible to ascribe a specific aetiology, which is termed ‘idiopathic’. Although autoimmunity has been implicated as a principal cause in 30–50%
Samia Aleem, Qazi Masood, Iffat Hassan
doaj   +1 more source

Cyclosporine for omalizumab-refractory chronic urticaria: a report of five cases

open access: yesAllergy, Asthma & Clinical Immunology, 2023
Background While both the AAAAI/ACAAI and the EAACI/GA2LEN/EuroGuiDerm/APAAACI guidelines recommend starting cyclosporine for patients with chronic urticaria who have had an inadequate response to omalizumab, many clinicians are hesitant to initiate ...
Anthony F. LaCava, Olajumoke O. Fadugba
doaj   +1 more source

A Perspective on the Use of NB-UVB Phototherapy vs. PUVA Photochemotherapy [PDF]

open access: yes, 2018
Narrowband UVB (NB-UVB) phototherapy and psoralen-UVA (PUVA) photochemotherapy are widely used phototherapeutic modalities for a range of skin diseases.
Ahmad   +119 more
core   +3 more sources

Response to Oral Dapsone in a Patient With Generalised Junctional Epidermolysis Bullosa

open access: yesJEADV Clinical Practice, EarlyView.
ABSTRACT Dapsone is a potent antibacterial agent used as a first‐line treatment for leprosy and employed also as an anti‐inflammatory agent. Additionally, dapsone is used for a variety of other cutaneous conditions. Herein, we report a case of intermediate junctional epidermolysis bullosa that improved significantly with oral 4,4’‐diamino‐diphenyl ...
Shiho Mori   +2 more
wiley   +1 more source

Urticaria. Interdisciplinary diagnostic and therapeutic recommendations of the Polish Dermatological Society and the Polish Society of Allergology

open access: yesPrzegląd Dermatologiczny, 2020
Urticaria has a complex aetiology and pathogenesis, and is characterized by the presence of wheals with accompanying pruritus or skin burning sensation. In 40% of cases, urticaria may be accompanied by angioedema. Depending on the duration, urticaria may
doaj   +1 more source

The postfinasteride syndrome; an overview [PDF]

open access: yes, 2016
As a 5-α reductase inhibitor, Finasteride has proven effective in ameliorating two conditions documented to be androgen dependent, namely male androgenic alopecia and benign prostatic hyperplasia. Therapeutic results are maintained as long as the drug is
Banu, Petrisor   +9 more
core   +4 more sources

Home - About - Disclaimer - Privacy